← Open Payments lookup

MELISSA QUICK: Open Payments

NPI 1639497910 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,351 in 73 payments from 14 companies in 2025. Trend: 2023 $1,558 · 2024 $1,754 · 2025 $1,351

Food & beverage: $1,351
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$242
Otsuka America Pharmaceutical, Inc.10$180
Alkermes, Inc.8$152
Lundbeck LLC10$140
Teva Pharmaceuticals USA, Inc.6$121
ABBVIE INC.5$101
Janssen Pharmaceuticals, Inc5$96
E.R. Squibb & Sons, L.L.C.5$92
Axsome Therapeutics, Inc.5$89
Neurocrine BioSciences, Inc.2$45

Products named: REXULTI, CAPLYTA, ARISTADA, VRAYLAR, INVEGA SUSTENNA, COBENFY, UZEDY, ABILIFY MAINTENA.

Industry payments across NE — which companies pay providers there.